TrialArthritis and rheumatism2013
Head-to-head comparison of subcutaneous abatacept versus adalimumab for rheumatoid arthritis: findings of a phase IIIb, multinational, prospective, randomized study.
Michael E Weinblatt et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
120 papers cite itlatest 60 shown
this paperpooled ittrialcites it